It is known that IL-22 has a pro-inflammatory effect in the presence of IL-17 and can be regulated by IL-17, the increase of Th17 cells in HBV-infected hepatocytes, produces more IL-22, forming a positive feedback loop, which promotes fibrosis and liver disease. This evidence concerns the gene IL22 and liver disorder.